Find N-Acetyl-L-Tyrosine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 537-55-3, Ac-tyr-oh, N-acetyl-tyrosine, Acetyl tyrosine, Acetyl-l-tyrosine, L-tyrosine, n-acetyl-
Molecular Formula
C11H13NO4
Molecular Weight
223.22  g/mol
InChI Key
CAHKINHBCWCHCF-JTQLQIEISA-N
FDA UNII
DA8G610ZO5

N-Acetyl-L-Tyrosine
N-acetyltyrosine, also referred to as N-acetyl-L-tyrosine, is used in place of as a tyrosine precursor. [DB00135] is a non-essential amino acid with a polar side group. N-acetyltyrosine is administered as parenteral nutrition or intravenous infusion due to its enhanced solubility compared to tyrosine. It is typically administered as a source of nutritional support where oral nutrition is inadequate or cannot be tolerated.
1 2D Structure

N-Acetyl-L-Tyrosine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoic acid
2.1.2 InChI
InChI=1S/C11H13NO4/c1-7(13)12-10(11(15)16)6-8-2-4-9(14)5-3-8/h2-5,10,14H,6H2,1H3,(H,12,13)(H,15,16)/t10-/m0/s1
2.1.3 InChI Key
CAHKINHBCWCHCF-JTQLQIEISA-N
2.1.4 Canonical SMILES
CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)O
2.1.5 Isomeric SMILES
CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
DA8G610ZO5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Acetyl-l-tyrosine

2. N-acetyltyrosine

3. N-acetyltyrosine, (d)-isomer

4. N-acetyltyrosine, (dl)-isomer

2.3.2 Depositor-Supplied Synonyms

1. 537-55-3

2. Ac-tyr-oh

3. N-acetyl-tyrosine

4. Acetyl Tyrosine

5. Acetyl-l-tyrosine

6. L-tyrosine, N-acetyl-

7. L-n-acetyltyrosine

8. N-acetyltyrosin

9. Melanowhite-a

10. (2s)-2-acetamido-3-(4-hydroxyphenyl)propanoic Acid

11. Tyrosine, N-acetyl-

12. Chembl65543

13. Da8g610zo5

14. Chebi:21563

15. (s)-2-acetamido-3-(4-hydroxyphenyl)propanoic Acid

16. (2s)-2-acetylamino-3-(4-hydroxyphenyl)propanoic Acid

17. N-acetyltyrosine (n-acetyl-l-tyrosine)

18. Ncgc00159393-02

19. Ncgc00159393-03

20. Dsstox_cid_26045

21. Dsstox_rid_81305

22. Dsstox_gsid_46045

23. (+)-(2s)-2-(acetylamino)-3-(4-hydroxyphenyl)propanoic Acid

24. Mfcd00037190

25. Cas-537-55-3

26. N-aceyl-l-tyrosine

27. L-tyrosine, Acetyl-

28. Tyrosine, N-acetyl-, L-

29. N-acetyltyrosine (van)

30. Unii-da8g610zo5

31. Nsc-10853

32. N-acetyl Tyrosine

33. Einecs 208-671-3

34. Nsc 10853

35. L-n-acetyl-tyrosine

36. Tanogen Hb

37. Tyr-excel

38. Acetyl L-tyrosine

39. N-acetyl-l-tyrosine,(s)

40. L-tyrosine, N-acetyl

41. Schembl321220

42. Acetyl Tyrosine [inci]

43. (2s)-2-(acetylamino)-3-(4-hydroxyphenyl)propanoic Acid

44. Dtxsid7046045

45. N-acetyltyrosin [who-dd]

46. Zinc156395

47. Tox21_111630

48. Ac7826

49. Bdbm50043802

50. S6316

51. Akos010396311

52. Akos015841008

53. N-acetyl-l-tyrosine [usp-rs]

54. N-acetyl-l-tyrosine, >99% (tlc)

55. Tox21_111630_1

56. Am82306

57. Cs-w013098

58. Db11102

59. Hy-w012382

60. N-acetyltyrosine [ep Monograph]

61. Ac-13390

62. Ds-15166

63. (2s)-2-acetylamino-3-(4-hydroxyphenyl)propanoate

64. (s)-2-acetamido-3-(4-hydroxyphenyl)propanoicacid

65. 537a553

66. A829762

67. J-300276

68. N-acetyl-l-tyrosine 100 Microg/ml In Acetonitrile

69. Q-201443

70. A53ee723-a216-4295-8abe-c8c9ee26bbfc

71. Q27109405

72. (s)-2-acetylamino-3-(4-hydroxy-phenyl)-propionic Acid

73. 2-(s)-acetylamino-3-(4-hydroxy-phenyl)-propionic Acid

74. N-acetyltyrosine, European Pharmacopoeia (ep) Reference Standard

75. N-acetyl-l-tyrosine, United States Pharmacopeia (usp) Reference Standard

76. N-acetyl-l-tyrosine, Pharmaceutical Secondary Standard; Certified Reference Material

77. 3nf

78. N-acetyl-l-tyrosine, Pharmagrade, Ajinomoto, Ep, Manufactured Under Appropriate Gmp Controls For Pharma Or Biopharmaceutical Production, Suitable For Cell Culture

2.4 Create Date
2005-07-08
3 Chemical and Physical Properties
Molecular Weight 223.22 g/mol
Molecular Formula C11H13NO4
XLogP3-0.2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass223.08445790 g/mol
Monoisotopic Mass223.08445790 g/mol
Topological Polar Surface Area86.6 Ų
Heavy Atom Count16
Formal Charge0
Complexity259
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

N-acetyltyrosine is indicated, in combination with several other amino acids and dextrose, as a peripherally administered source of nitrogen for nutritional support in patients with adequate stores of body fat in whom, for short periods, oral administration cannot be tolerated, is undesirable, or inadequate. It is also indicated, with other amino acids, 5-10% dextrose, and fat emulsion, for parenteral nutrition to preserve protein and reduce catabolism in stress conditions where oral administration is inadequate. When administered with other amino acids and concentrated dextrose, it is indicated for central vein infusion to prevent or reverse negative nitrogen balance in patients where the alimentary tract by the oral, gastrostomy, or jejestomy routes cannot or should not be used or in patients in which gastrointestinal absorption of protein is impaired, metabolic requirements for protein are substantially increased, or morbidity and mortality may be reduced by replacing amino acids lost from tissue breakdown


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

N-acetyltyrosine is used as a high solubility precursor to [DB00135] used due to [DB00135]'s poor solubility. It is deacetylated to form [DB00135].


5.2 Absorption, Distribution and Excretion

Route of Elimination

N-acetyltyrosine is eliminated in the urine. The extent of urinary elimination versus utilization in the tissues appears to be related to the rapidity of infusion. When infused slowly in standard doses as in the clinical setting, about 35% is excreted unchanged in the urine. When larger doses are infused rapidly, much higher amounts are excreted reaching values up to 56%. In rat studies it was found that of the drug eliminated in the urine about 74% is present as unchanged N-acetyltyrosine and 23% is present as tyrosine.


5.3 Mechanism of Action

Used as a source of [DB00135]. See [DB00135] for more information on its role and pharmacology.


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"N-ACETYL-L-TYROSINE","year":"2021","qtr":"Q2","strtotime":1619634600,"product":"N-ACETYL-L-TYROSINE (L- ACETYLTYROSINE BP) - (UNDER PC9 CONDITION) - AS PER INVOICE","address":"5TH FLOOR , CLARIS CORPORATE HQ NR, PARIMAL CROSSING , ELLISBRIDGE,","city":"AHMEDABAD - GUJRAT","supplier":"AMINO GMBH","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"OTSUKA HOLDINGS","customerCountry":"INDIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"333.5","totalValueFC":"616.5","currency":"EUR","unitRateINR":"30598.6","date":"29-Apr-2021","totalValueINR":"45897.94","totalValueInUsd":"616.5","indian_port":"BOMBAY AIR","hs_no":"29224990","bill_no":"3757285","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"","customerAddress":"5TH FLOOR , CLARIS CORPORATE HQ NR, PARIMAL CROSSING , ELLISBRIDGE,"},{"dataSource":"API Import","activeIngredients":"N-ACETYL-L-TYROSINE","year":"2021","qtr":"Q2","strtotime":1619634600,"product":"N-ACETYL-L-TYROSINE (L- ACETYLTYROSINE BP) - (UNDER PC9 CONDITION) - AS PER INVOICE","address":"5TH FLOOR , CLARIS CORPORATE HQ NR, PARIMAL CROSSING , ELLISBRIDGE,","city":"AHMEDABAD - GUJRAT","supplier":"AMINO GMBH","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"OTSUKA HOLDINGS","customerCountry":"INDIA","quantity":"4.07","actualQuantity":"4.07","unit":"KGS","unitRateFc":"333.5","totalValueFC":"1672.8","currency":"EUR","unitRateINR":"30598.6","date":"29-Apr-2021","totalValueINR":"124536.4","totalValueInUsd":"1672.8","indian_port":"BOMBAY AIR","hs_no":"29224990","bill_no":"3757285","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"","customerAddress":"5TH FLOOR , CLARIS CORPORATE HQ NR, PARIMAL CROSSING , ELLISBRIDGE,"},{"dataSource":"API Import","activeIngredients":"N-ACETYL-L-TYROSINE","year":"2021","qtr":"Q2","strtotime":1619634600,"product":"N-ACETYL-L-TYROSINE (L- ACETYLTYROSINE BP) - (UNDER PC9 CONDITION) - AS PER INVOICE","address":"5TH FLOOR , CLARIS CORPORATE HQ NR, PARIMAL CROSSING , ELLISBRIDGE,","city":"AHMEDABAD - GUJRAT","supplier":"AMINO GMBH","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"OTSUKA HOLDINGS","customerCountry":"INDIA","quantity":"11.30","actualQuantity":"11.3","unit":"KGS","unitRateFc":"333.5","totalValueFC":"4644.3","currency":"EUR","unitRateINR":"30598.6","date":"29-Apr-2021","totalValueINR":"345764.46","totalValueInUsd":"4644.3","indian_port":"BOMBAY AIR","hs_no":"29224990","bill_no":"3757285","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"","customerAddress":"5TH FLOOR , CLARIS CORPORATE HQ NR, PARIMAL CROSSING , ELLISBRIDGE,"},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1639506600,"product":"N-ACETYL-L-TYROSINE (CAS NO :537-55-3) (R&D TESTING PURPOSES ONLY )(SAMPLE)(FOC)","address":"706, 707, 7TH FLOOR, QUANTUM TOWER ,,RAM BAUG LANE, OFF. S. V. ROAD,","city":"MALAD WEST,MAHARASHTRA","supplier":"AMINO GMBH","supplierCountry":"GERMANY","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"GANGWAL CHEMICALS","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"66.7","totalValueFC":"13.2","currency":"EUR","unitRateINR":"9944","date":"15-Dec-2021","totalValueINR":"994.4","totalValueInUsd":"13.2","indian_port":"BOMBAY AIR","hs_no":"29242990","bill_no":"6681846","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"FRANKFURT\/MAIN INT\\'L","supplierAddress":"","customerAddress":"706, 707, 7TH FLOOR, QUANTUM TOWER ,,RAM BAUG LANE, OFF. S. V. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664994600,"product":"N-ACETYL-L-TYROSINE- (ACETYLTYROSINE BP) - AS PER INVOICE","address":"20TH-21ST FLOOR, B-BLOCK, WESTGATE ,,NR. YMCA CLUB, S.G. HIGHWAY,","city":"AHMEDABAD,GUJARAT","supplier":"KYOWA HAKKO BIO","supplierCountry":"JAPAN","foreign_port":"NA","customer":"OTSUKA HOLDINGS","customerCountry":"INDIA","quantity":"12.78","actualQuantity":"12.78","unit":"KGS","unitRateFc":"140","totalValueFC":"1748.2","currency":"USD","unitRateINR":"11256","date":"06-Oct-2022","totalValueINR":"143851.68","totalValueInUsd":"1748.2","indian_port":"BOMBAY AIR","hs_no":"29224990","bill_no":"2762785","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"20TH-21ST FLOOR, B-BLOCK, WESTGATE ,,NR. YMCA CLUB, S.G. HIGHWAY,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1664994600,"product":"N-ACETYL-L-TYROSINE- (ACETYLTYROSINE BP) - AS PER INVOICE","address":"20TH-21ST FLOOR, B-BLOCK, WESTGATE ,,NR. YMCA CLUB, S.G. HIGHWAY,","city":"AHMEDABAD,GUJARAT","supplier":"KYOWA HAKKO BIO","supplierCountry":"JAPAN","foreign_port":"NA","customer":"OTSUKA HOLDINGS","customerCountry":"INDIA","quantity":"16.10","actualQuantity":"16.1","unit":"KGS","unitRateFc":"140","totalValueFC":"2202.4","currency":"USD","unitRateINR":"11256","date":"06-Oct-2022","totalValueINR":"181221.6","totalValueInUsd":"2202.4","indian_port":"BOMBAY AIR","hs_no":"29224990","bill_no":"2762785","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"20TH-21ST FLOOR, B-BLOCK, WESTGATE ,,NR. YMCA CLUB, S.G. HIGHWAY,"}]
29-Apr-2021
06-Oct-2022
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty